Understanding how enzymes activate C-H bonds for better catalysts
Revealing Nature's Blueprints for Single-Site Catalysis of C-H Activation with First-principles Modeling and Machine Learning
This study is exploring how special enzymes can help create important small molecules by activating certain bonds, and it's designed for anyone interested in improving medicine and making valuable compounds more efficiently.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11141792 on NIH RePORTER |
What this research studies
This research investigates how certain enzymes, particularly non-heme iron enzymes, can selectively activate C-H bonds, a process crucial for creating various small molecules. By using advanced computational modeling and machine learning, the research aims to uncover the mechanisms behind these enzymatic reactions and develop new catalysts that can mimic their efficiency. This could lead to breakthroughs in medicinal chemistry and the production of valuable compounds. The approach combines theoretical insights with practical applications to enhance our understanding of biological catalysis.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated with new drugs developed through improved catalytic processes.
Not a fit: Patients who are not seeking new treatment options or those with conditions unrelated to drug synthesis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective catalysts for drug synthesis and other important chemical processes.
How similar studies have performed: Other research has shown promise in using computational modeling and machine learning to enhance catalytic processes, indicating a potential for success in this novel approach.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Kulik, Heather J. — Massachusetts Institute of Technology
- Study coordinator: Kulik, Heather J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.